I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Florou, Vaia
35
results:
Search for persons
X
Format
Online (35)
Mediatypes
Articles (Online) (15)
Bookchapter (Online) (1)
OpenAccess-fulltext (19)
Sorted by: Relevance
Sorted by: Year
?
1
Cutaneous Side Effects of Modern Targeted Therapy and Immun..:
Plachouri, Kerasia-Maria
;
Florou, Vaia
;
Georgiou, Vasileios
.
Cancers. 15 (2023) 12 - p. 3126 , 2023
Link:
https://doi.org/10.3390/..
?
2
Real-world pan-cancer landscape of frameshift mutations and..:
Florou, Vaia
;
Floudas, Charalampos S
;
Maoz, Asaf
...
Journal for ImmunoTherapy of Cancer. 11 (2023) 8 - p. e007440 , 2023
Link:
https://doi.org/10.1136/..
?
3
Treatment outcomes in recurrent versus de novo metastatic p..:
Miotke, Laura
;
Nevala-Plagemann, Christopher
;
Ying, Jian
...
BMC Cancer. 22 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
4
Clinical Development of Anti-TIGIT Antibodies for Immunothe..:
Florou, Vaia
;
Garrido-Laguna, Ignacio
Current Oncology Reports. 24 (2022) 9 - p. 1107-1112 , 2022
Link:
https://doi.org/10.1007/..
?
5
Considerations for treatment duration in responders to immu..:
Marron, Thomas U
;
Ryan, Aideen E
;
Reddy, Sangeetha M
...
Journal for ImmunoTherapy of Cancer. 9 (2021) 3 - p. e001901 , 2021
Link:
https://doi.org/10.1136/..
?
6
Current Management of Angiosarcoma: Recent Advances and Les..:
Florou, Vaia
;
Wilky, Breelyn A.
Current Treatment Options in Oncology. 22 (2021) 7 - p. , 2021
Link:
https://doi.org/10.1007/..
?
7
Immunotherapy and fatigue: what we know and what we don't k..:
Azeem Khan, Muhammad
;
Florou, Vaia
;
Swami, Umang
Oncotarget. 12 (2021) 8 - p. 719-720 , 2021
Link:
https://doi.org/10.18632..
?
8
A 51-year-old man with chronic cough and left hilar promine..:
Kourouni, Ismini
;
Aesif, Scott W.
;
Tamarkin, Stephen W.
...
Breathe. 17 (2021) 2 - p. 210018 , 2021
Link:
https://doi.org/10.1183/..
?
9
Outcomes associated with immune-related adverse events in m..:
Naqash, Abdul Rafeh
;
Ricciuti, Biagio
;
Owen, Dwight H.
...
Cancer Immunology, Immunotherapy. 69 (2020) 7 - p. 1177-1187 , 2020
Link:
https://doi.org/10.1007/..
?
10
Correction to: Outcomes associated with immune-related adve..:
Naqash, Abdul Rafeh
;
Ricciuti, Biagio
;
Owen, Dwight H.
...
Cancer Immunology, Immunotherapy. 69 (2020) 7 - p. 1189-1189 , 2020
Link:
https://doi.org/10.1007/..
?
11
Angiosarcoma patients treated with immune checkpoint inhibi..:
Florou, Vaia
;
Rosenberg, Andrew E.
;
Wieder, Eric
...
Journal for ImmunoTherapy of Cancer. 7 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1186/..
?
12
Correction to: Angiosarcoma patients treated with immune ch..:
Florou, Vaia
;
Rosenberg, Andrew E.
;
Wieder, Eric
...
Journal for ImmunoTherapy of Cancer. 7 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1186/..
?
13
Regulatory T cells:
, In:
Immunotherapy of Sarcoma
,
Florou, Vaia
;
Wilky, Breelyn A.
- p. 33-45 , 2018
Link:
https://doi.org/10.1007/..
?
14
Current and Future Directions for Angiosarcoma Therapy:
Florou, Vaia
;
Wilky, Breelyn A.
Current Treatment Options in Oncology. 19 (2018) 3 - p. , 2018
Link:
https://doi.org/10.1007/..
?
15
Safety of High-Dose Melphalan (200 Mg/M2) as Conditioning f..:
Desai, Amrita
;
Beitinjaneh, Amer
;
Ramdial, Jeremy
...
Biology of Blood and Marrow Transplantation. 23 (2017) 3 - p. S133-S134 , 2017
Link:
https://doi.org/10.1016/..
1-15